VANDA PHARMACEUTICALS INC.

Analyst Reco. Vanda Pharmaceuticals Inc.

Equities

VNDA

US9216591084

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 18:48:33 10/12/2025 GMT			5-day change	1st Jan Change
6.445 ^USD	+6.35%		+23.91%	+36.33%

12-04	Vanda Says FDA Lifts Partial Hold on Tradipitant Motion-Sickness Study	MT
12-04	FDA Lifts Hold on Vanda Pharmaceuticals' Motion Sickness Drug	DJ

Analyst Reco.

B. Riley Initiates Coverage on Vanda Pharmaceuticals With Buy Rating, $11 Price Target	11-05	MT
Vanda Pharmaceuticals Q2 revenue up 4%	07-31	RE
HC Wainwright Starts Vanda Pharmaceuticals With Buy Rating, $18 Price Target	31/10/24	MT
Cantor Fitzgerald Initiates Vanda Pharmaceuticals at Overweight With $11 Price Target	11/07/24	MT
The same old winners	27/06/24
Jefferies Downgrades Vanda Pharmaceuticals to Hold From Buy, Adjusts Price Target to $12 From $24	25/02/22	MT
VANDA PHARMACEUTICALS : BofA Securities Starts Vanda Pharmaceuticals at Buy With $22 Price Target	12/05/21	MT
VANDA PHARMACEUTICALS : Citigroup Downgrades Vanda Pharmaceuticals to Neutral From Buy; Price Target is $14	14/01/21	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Rankings

More Top / Flop

Rankings

More Top / Flop

Currency / Forex

Commodities

Cryptocurrencies

Cryptocurrencies

The best tools reserved for subscribers to boost the performance of your investments!